Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01859156 · ClinicalTrials.gov registry record
End-Tidal Carbon Dioxide as a Measure of Carboxyhemoglobin in Carbon Monoxide Poisoning
A clinical trial, sponsored by Hennepin Healthcare Research Institute.
- Completed
- Registry status
- 151
- Enrollment target
NCT01859156: Completed study, sponsored by Hennepin Healthcare Research Institute.
NCT01859156 is a clinical trial that has completed, run by Hennepin Healthcare Research Institute. The registered enrollment target is 151 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01859156 has completed, sponsored by Hennepin Healthcare Research Institute.
- COMPLETED
- Registry status
- 151 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a relationship exists between EtCO2 and carboxyhemoglobin levels in carbon monoxide exposure. Our hypothesis is that a liner relationship exists between EtCO2 and carboxyhemoglobin in carbon monoxide poisoning.
Primary Outcome
The EtCO2 level is measured by capnography and compared to the carboxyhemoglobin level.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2006-10 |
| Est. Completion | 2014-07 |
What the finished NCT01859156 record still lists
NCT01859156 is an observational study that tracks outcomes without assigning an intervention. The registered 151 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01859156 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01859156 about?
NCT01859156 is a clinical study titled "End-Tidal Carbon Dioxide as a Measure of Carboxyhemoglobin in Carbon Monoxide Poisoning". The purpose of this study is to determine whether a relationship exists between EtCO2 and carboxyhemoglobin levels in carbon monoxide exposure. Our hypothesis is that a liner relationship exists between EtCO2 and carboxyhemoglobin in carbon monoxide poisoning.
What is the current status of trial NCT01859156?
This trial is currently completed. The enrollment target is 151 participants. The study started on 2006-10. Estimated completion is 2014-07.
Who is sponsoring clinical trial NCT01859156?
This trial is sponsored by Hennepin Healthcare Research Institute, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01409161 · 151 participants · Phase 2
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
- NCT04245397 · 151 participants · Phase 1
Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
- NCT05761223 · 151 participants · Phase 1
A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849
- NCT07195656 · 151 participants · NA
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia